Eiko Lifesciences Ltd — Important, 09-04-2026: Company Update

Eiko Lifesciences announced its status as of March 31, 2026. The company is not categorized as a "Large Corporate" under the specified criteria for fundraising through debt securities. This means the framework for large corporates concerning debt issuance and related annual disclosures does not apply to Eiko Lifesciences. The company is therefore exempt from filing initial and annual disclosures under this particular regulatory requirement. This clarification informs stakeholders about the company's compliance obligations and reporting status regarding debt financing.